SCHEMBL6678873

SCHEMBL6678873

C=Cc1ccccc1C(=O)CC(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 3/20 0.40
FEN1 P39748 3/20 0.40
PTPN1 P18031 1/20 0.40
MAPT P10636 5/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
KDM4E B2RXH2 2/20 0.38
RAB9A P51151 2/20 0.38
KCNH2 Q12809 1/20 0.38
CYP3A4 P08684 2/20 0.38
HPGD P15428 4/20 0.38
ALOX15 P16050 3/20 0.38
MAPK1 P28482 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CES1 P23141 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 3/20 0.37
NPC1 O15118 2/20 0.37
CYP1A2 P05177 1/20 0.37
TGM2 P21980 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5369405 0.84 ERCC5 (0.39) ERCC5FEN1PTPN1MAPTKMT2A
SCHEMBL6342612 0.81 CYP3A4 (0.40) PTPN1MAPTKMT2AMEN1KDM4E
SCHEMBL27612063 0.80 ALDH1A1 (0.54) MAPTKMT2AMEN1KDM4EHPGD
SCHEMBL19971468 0.80 MEN1 (0.46) MAPTKMT2AMEN1KDM4ERAB9A
SCHEMBL7515781 0.79 ALDH1A1 (0.45) MAPTKMT2AKDM4ERAB9ACYP3A4
SCHEMBL28713351 0.79 CYP3A4 (0.39) PTPN1KMT2AKDM4ECYP3A4HPGD
SCHEMBL28169041 0.79 CYP3A4 (0.43) PTPN1MAPTKMT2AMEN1KDM4E
SCHEMBL10623096 0.79 PTPN1 (0.50) PTPN1MAPTKDM4ECYP3A4HPGD
SCHEMBL9720642 0.79 MAPT (0.40) MAPTKMT2AKDM4ECYP3A4HPGD
SCHEMBL9356372 0.79 ERCC5 (0.41) ERCC5FEN1PTPN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1476433-A1 NOVEL TRICYCLOIMIDAZOLINE DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2004-11-17 EP disclosed
WO-2003068755-A1 NOVEL TRICYCLOIMIDAZOLINE DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS PIERRE FABRE MEDICAMENT (FR) 2003-08-21 WO disclosed